Chinese drug regulator becomes world’s fastest
Bloomberg China is blowing through regulatory milestones as it completes an astonishing transformation from a market where basic Western drugs were once scarce to one where life-saving treatments are available ahead of the US — all in less than a year. The latest announcement that China has approved an anemia treatment from AstraZeneca Plc and FibroGen Inc. ahead of the ...
Read More »